Premium
Photodynamic therapy for pathogenic fungi
Author(s) -
Lyon Juliana Pereira,
Moreira Leonardo Marmo,
de Moraes Pedro Claudio Guaranho,
dos Santos Fábio Vieira,
de Resende Maria Aparecida
Publication year - 2011
Publication title -
mycoses
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.13
H-Index - 69
eISSN - 1439-0507
pISSN - 0933-7407
DOI - 10.1111/j.1439-0507.2010.01966.x
Subject(s) - photodynamic therapy , candida albicans , microbiology and biotechnology , antimicrobial , antifungal drug , antifungal , biology , protozoa , photosensitizer , chemistry , photochemistry , organic chemistry
Summary Photodynamic therapy (PDT) is a minimally invasive approach, in which a photosensitiser compound is activated by exposure to visible light. The activation of the sensitiser drug results in several chemical reactions, such as the production of oxygen reactive species and other reactive molecules, whose presence in the biological site leads to the damage of target cells. Although PDT has been primarily developed to combat cancerous lesions, this therapy can be employed for the treatment of several conditions, including infectious diseases. A wide range of microorganisms, including Gram positive and Gram negative bacteria, viruses, protozoa and fungi have demonstrated susceptibility to antimicrobial photodynamic therapy. This treatment might consist of an alternative to the management of fungal infections. Antifungal photodynamic therapy has been successfully employed against Candida albicans and other Candida species and also against dermatophytes. The strain‐dependent antifungal effect and the influence of the biological medium are important issues to be considered. Besides, the choice of photosensitiser to be employed in PDT should consider the characteristics of the fungi and the medium to be treated, as well as the depth of penetration of light into the skin. In the present review, the state‐of‐the‐art of antifungal PDT is discussed and the photosensitiser characteristics are analysed.